GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN

被引:221
作者
BAILEY, DG
ARNOLD, JMO
MUNOZ, C
SPENCE, JD
机构
[1] Victoria Hospital, University of Western Ontario
关键词
D O I
10.1038/clpt.1993.84
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Grapefruit juice produces a marked and variable increase in felodipine bioavailability. The pharmacokinetics of felodipine and its single primary oxidative metabolite, dehydrofelodipine, were studied after drug administration with 200 ml water, grapefruit juice, or naringin in water at the same concentration as the juice in a randomized crossover trial of nine healthy men. With grapefruit juice, mean +/- SEM felodipine area under the plasma concentration-time curve (AUC) and peak plasma concentration (C(max)) were 206% +/- 23% (range, 123% to 330%, p < 0.01) and 170% +/- 24% (range, 127% to 310%, p < 0.02), respectively, compared with water. Dehydrofelodipine/felodipine ratios for AUC (1.5 +/- 0.2 versus 2.2 +/- 0.2, p < 0.001) and felodipine C(max) (1.5 +/- 0.2 versus 2.2 +/- 0.2, p < 0.001) were reduced, consistent with inhibition of presystemic felodipine metabolism. Intersubject changes in felodipine and dehydrofelodipine AUC supported inhibition of both primary and secondary metabolic steps as a mechanism. The interaction could not be predicted from baseline pharmacokinetics with water and did not result in more consistent bioavailability among individuals. Naringin solution produced much less of an interaction, showing that other factors were important.
引用
收藏
页码:637 / 642
页数:6
相关论文
共 17 条
  • [1] Ahnoff M, 1984, J Pharm Biomed Anal, V2, P519, DOI 10.1016/0731-7085(84)80055-2
  • [2] INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE
    BAILEY, DG
    SPENCE, JD
    MUNOZ, C
    ARNOLD, JMO
    [J]. LANCET, 1991, 337 (8736) : 268 - 269
  • [3] BAILEY DG, 1992, CLIN PHARMACOL THER, V51, P156
  • [4] A POPULATION STUDY OF THE PHARMACOKINETICS OF FELODIPINE
    BLYCHERT, E
    EDGAR, B
    ELMFELDT, D
    HEDNER, T
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (01) : 15 - 24
  • [5] BUENING MK, 1981, CANCER RES, V41, P67
  • [6] INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE
    CHAYEN, R
    ROSENTHAL, T
    [J]. LANCET, 1991, 337 (8745) : 854 - 854
  • [7] EDGAR B, 1992, EUR J CLIN PHARMACOL, V42, P313
  • [8] FELODIPINE KINETICS IN HEALTHY-MEN
    EDGAR, B
    REGARDH, CG
    JOHNSSON, G
    JOHANSSON, L
    LUNDBORG, P
    LOFBERG, I
    RONN, O
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 205 - 211
  • [9] OXIDATION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS AND ANALOGS BY HUMAN LIVER CYTOCHROME-P-450 IIIA4
    GUENGERICH, FP
    BRIAN, WR
    IWASAKI, M
    SARI, MA
    BAARNHIELM, C
    BERNTSSON, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) : 1838 - 1844
  • [10] GUENGERICH FP, 1990, CARCINOGENESIS, V11, P2275, DOI 10.1093/carcin/11.12.2275